Concerns Rise as Unvalidated Blood Pressure Wearables Enter Market Following FDA Oversight Changes
The market is seeing an influx of wearables claiming to measure blood pressure without validation, a trend that follows the FDA's recent easing of regulations on wellness devices.
Editorial Staff
1 min read
Updated 12 days ago
Recent changes in FDA regulations have led to a surge in the availability of wearables that claim to measure blood pressure, despite lacking validation.
These devices are entering the market at a time when consumer interest in health technology is high, but the lack of oversight raises concerns about their accuracy and reliability.
As the wellness device market expands, it is crucial for consumers to approach these unvalidated products with caution, given the potential implications for health monitoring.